Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
India’s largest drugmaker underscores that precision—designing drugs to reduce side effects and improve delivery for very specific patient needs—beats scattershot expansion, Executive Chairman Dilip Shanghvi said, noting annual R&D of about $450 million, strong specialty anchors like Ilumya (FY25 sales ~$681m), and momentum from Leqselvi in alopecia areata; two-thirds of revenue now comes from international markets, and even the long, messy Ranbaxy integration “doesn’t mean the strategy was wrong—only execution must improve.”
You May Interested In
2026-09-07
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
USDA Puts Fresh Money Into Local Food Markets
-
"No available slots" returns as global shipping rates skyrocket amid multiple factors
-
Domo Chemicals’ German Subsidiary Insolvencies: Energy Costs, Weak Demand and Chinese Nylon Competition
-
The Carbon Tollbooth Is Open: EU’s CBAM Ushers in a New Era of Climate-Linked Trade
-
Sherwin-Williams Surpasses $100 Billion in Market Cap: Is This the ‘Apple Moment’ for Paint, or America’s Industrial ‘One Hundred Years of Solitude’?
-
Carbon Fiber’s Price Surge Signals a New Era of Strategic Value—and Supply Tension
-
EU Greenlights Four GM Crops—But Only at the Border
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
“Anti-Overcapacity” Backfires: China’s Chemical Industry Trapped in a Hell of Its Own Making—and Global Pushback
Recommend Reading
-
![Iran's Only MDI/TDI Plant Attacked, Middle East Supply Nearly Zero, Global Gap Widens]()
Iran's Only MDI/TDI Plant Attacked, Middle East Supply Nearly Zero, Global Gap Widens
-
![Three Major Indian Chemical Investments Target China's PC Exports]()
Three Major Indian Chemical Investments Target China's PC Exports
-
![ADNOC Reroutes Naphtha via Oman to Bypass Hormuz Risk]()
ADNOC Reroutes Naphtha via Oman to Bypass Hormuz Risk
-
![US MDI Supply Squeeze Triggers Price Hikes]()
US MDI Supply Squeeze Triggers Price Hikes
-
![Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou]()
Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou
-
![DMF Supply Tightens in Early April, Prices Remain Strong]()
DMF Supply Tightens in Early April, Prices Remain Strong
-
![Dichloromethane 2025 Review and 2026 Outlook — Carrying Forward, Stalemate Persists]()
Dichloromethane 2025 Review and 2026 Outlook — Carrying Forward, Stalemate Persists
-
![Business Society’s PTA Market Outlook on August 31, 2026: Volatile]()
Business Society’s PTA Market Outlook on August 31, 2026: Volatile
-
![Multiple Positive Factors Support a Rise in the Butadiene Market]()
Multiple Positive Factors Support a Rise in the Butadiene Market
-
![Sell Signal Alert! Melamine Drops Sharply to]()
Sell Signal Alert! Melamine Drops Sharply to "Low Position" in 10 Days, Short-term Momentum Weakens
